Navigation Links
Common ancestry of bacterium and plants could be key to an effective new treatment for chlamydia

Rutgers researchers have discovered that the Chlamydia bacterium, which causes a sexually transmitted disease (STD), shares an evolutionary heritage with plants. That shared evolutionary heritage, which is not found in most other bacteria, points to a prime target for development of an effective cure for Chlamydia infections.

"The unique connection between the Chlamydia bacterium and plants had been proposed by others," said Thomas Leustek," a professor in the department of plant biology and pathology at Rutgers' School of Environmental and Biological Sciences (formerly Cook College). "But we have now described a specific example demonstrating the common heritage. That specific example, an enzyme that supports protein production, could lead to antibiotics specific for this form of STD."

The discovery is an unexpected turn in solving the mystery of how plants produce lysine, one of the 20 amino acids normally found in proteins. Scientists have known the specific pathways of lysine production in bacteria for more than a half-century. They also have known some of the steps by which lysine is produced in plants, but they didn't really have the full picture. Leustek and Andre Hudson, a postdoc working in Leustek's lab in Rutgers' Biotechnology Center for Agriculture and the Environment, were able to solve the pathway when they discovered the gene encoding the enzyme L,L-diaminopimelate aminotransferase from the plant Arabdiopsis thaliana. The results of this discovery were published in the journal Plant Physiology in January 2006.

The gene that Leustek and Hudson had discovered was unmistakably similar to a sequence that Anthony Maurelli of the Uniformed Services University of the Health Sciences in Bethesda, Md., had detected in Chlamydia. "Further experimentation confirmed that the Chlamydial gene had the same function as the Arabidopisis gene demonstrating their common ancestry," said Leustek. "If they had evolved separately, it would be imp ossible for the sequences to match so closely."

The ability to easily compare plants and bacteria is the result of genome sequencing, which has decoded the complete genetic blueprint for entire species. "This would not have been possible 10 years ago," said Leustek. "But now we have access to more that 500 different genomes in a data base. After having identified a gene in plants, I can quickly identify the homologous gene from any bacteria in the database. As a plant biologist I wouldn't have ever imagined that I would be working with Chlamydia. Yet, with the help of genomics I found myself working with a collaborator and publishing a paper in that area."

Their experiments revealed that in addition to sharing genome sequences, Chlamydia and plants share similar functions as well. Furthermore, they found that the pathway used by plants to produce lysine is probably used by Chlamydia to synthesize a chemical found in bacterial cell walls. It is the synthesis of cell walls that is inhibited by penicillin. This discovery points to the likelihood that, if researchers could find an inhibitor for L,L-diaminopimelate aminotransferase they would have a new antibiotic that would target Chlamydia.

Chlamydia trachomatis is a bacteria that is responsible for a common STD. If untreated, Chlamydia infections can damage a woman's reproductive organs and lead to infertility. An estimated 2.8 million men and women in the U.S. are infected with chlamydia each year. Chlamydia can be easily treated and cured with antibiotics. However, bacteria often develop resistance to antibiotics, meaning that new ones must be continually discovered. Moreover, an inhibitor to L,L-diaminopimelate aminotransferase would be very specific for Chlamydia since this enzyme has not been found in any bacteria that live with humans.

So the hunt for a new antibiotic is on. Leustek is going to start screening for chemicals that block the enzyme. He is also using the res ults of his research to work on another approach, which is to characterize the structure of the enzyme so that he could design an antibiotic that would disable the pathway. This approach is somewhat like designing a key to fit a lock by opening the lock and looking inside.

The research is being done in collaboration with Charles Gilvarg from Princeton University. "He's the biochemist who characterized the lysine pathway back in the 1950s, and so he had intimate knowledge about the steps of the pathway," said Leustek. "And he's the one that alerted us to the fact that plants do it differently. This is still the case, with the exception of the Chlamydia bacterium."
'"/>

Source:Rutgers, the State University of New Jersey


Related biology news :

1. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
2. Harmful Bacterium Commonly Found in Poultry May Survive Refrigeration and Frozen Storage Combined
3. Men Estimate Mens Risks Of Common Disorders Higher Than Women Do, And Vice Versa
4. Use of Antibiotics for Acne May Increase Risk of Common Illness
5. Common viruses may cause cancer
6. Common alternative treatment for liver disease is found to be ineffective
7. Common molecular signature identified in solid tumors
8. Common bacteria pirate natural mechanism to get inside cells
9. Commonly used antidepressants may also affect human immune system
10. Common practices at petting zoos put visitors at risk
11. Common enzyme is a key player in DNA repair

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/22/2016)... , January 22, 2016 ... the addition of the  "Global Behavioral ... offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ... "Global Behavioral Biometric Market 2016-2020"  report ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has ...
(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
(Date:1/11/2016)... , Jan. 11, 2016 Synaptics Incorporated ... interface solutions, today announced that its ClearPad ® ... (TDDI) products won two separate categories in the 8 ... Innovator and Best Technology Breakthrough. The Synaptics ® ... a simplified supply chain, thinner devices, brighter displays and ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... New York, NY (PRWEB) , ... ... ... International (BPI), a business-to-business publication dedicated to delivering cutting-edge information focused on ... GE Healthcare Life Sciences to become a premier sponsor of the 2016 ...
(Date:2/11/2016)... WASHINGTON , Feb. 11, 2016   BioInformant ... strategic report, "Stem Cell Research Products, Opportunities, Tools, and ... 2020. ... specialize in the stem cell industry, BioInformant has more ... of the stem cell market, by stem cell type. ...
(Date:2/11/2016)... ... , ... Global Stem Cells Group, has announced ... new facility will provide advanced protocols and state-of-the-art techniques in cellular medicine, focusing ... The new GSCG clinic is headed by four prominent Ecuadorian physicians, including Pablo ...
(Date:2/10/2016)... -- The Maryland House of Delegates and House Speaker ... Maryland School of Medicine Dean E. Albert Reece ... System President and CEO Robert Chrencik , MBA, ... given to the public by the leader of the ... and Mr. Chrencik for their contributions to our statewide ...
Breaking Biology Technology: